243 related articles for article (PubMed ID: 22718504)
1. Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy.
Kasznicki J; Kosmalski M; Sliwinska A; Mrowicka M; Stanczyk M; Majsterek I; Drzewoski J
Mol Biol Rep; 2012 Sep; 39(9):8669-78. PubMed ID: 22718504
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms (Pro197Leu of Gpx1, +35A/C of SOD1, -262C/T of CAT), the level of antioxidant proteins (GPx1, SOD1, CAT) and the risk of distal symmetric polyneuropathy in Polish patients with type 2 diabetes mellitus.
Kasznicki J; Sliwinska A; Kosmalski M; Merecz A; Majsterek I; Drzewoski J
Adv Med Sci; 2016 Mar; 61(1):123-9. PubMed ID: 26674569
[TBL] [Abstract][Full Text] [Related]
3. Analysis of oxidative DNA damage and its repair in Polish patients with diabetes mellitus type 2: Role in pathogenesis of diabetic neuropathy.
Merecz A; Markiewicz L; Sliwinska A; Kosmalski M; Kasznicki J; Drzewoski J; Majsterek I
Adv Med Sci; 2015 Sep; 60(2):220-30. PubMed ID: 25932787
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of oxidative DNA damage and antioxidant defense in patients with nasal polyps.
Mrowicka M; Zielinska-Blizniewska H; Milonski J; Olszewski J; Majsterek I
Redox Rep; 2015 Jul; 20(4):177-83. PubMed ID: 25584923
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma.
Majsterek I; Malinowska K; Stanczyk M; Kowalski M; Blaszczyk J; Kurowska AK; Kaminska A; Szaflik J; Szaflik JP
Exp Mol Pathol; 2011 Apr; 90(2):231-7. PubMed ID: 21241689
[TBL] [Abstract][Full Text] [Related]
6. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity.
Khalili F; Vaisi-Raygani A; Shakiba E; Kohsari M; Dehbani M; Naseri R; Asadi S; Rahimi Z; Rahimi M; Rahimi Z
J Clin Lab Anal; 2022 Jan; 36(1):e24163. PubMed ID: 34861061
[TBL] [Abstract][Full Text] [Related]
8. Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy.
Xiong Q; Lu B; Ye HY; Liu SY; Zheng HP; Zhang RY; Qiao XN; Zhang S; Liu XX; Li QC; Yi N; Wu LC; Wen J; Zhang TS; Li YM
Diabetes Res Clin Pract; 2018 Feb; 136():85-92. PubMed ID: 29221815
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
10. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
[TBL] [Abstract][Full Text] [Related]
11. Altered glutathione system is associated with the presence of distal symmetric peripheral polyneuropathy in type 2 diabetic subjects.
Mendez MM; Folgado J; Tormo C; Artero A; Ascaso M; Martinez-Hervás S; Chaves FJ; Ascaso JF; Real JT
J Diabetes Complications; 2015; 29(7):923-7. PubMed ID: 26144280
[TBL] [Abstract][Full Text] [Related]
12. Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk.
Stoian A; Bănescu C; Bălaşa RI; Moţăţăianu A; Stoian M; Moldovan VG; Voidăzan S; Dobreanu M
Dis Markers; 2015; 2015():638693. PubMed ID: 26435566
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Strom A; Bönhof GJ; Heier M; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
Diabetes Metab Res Rev; 2018 Jul; 34(5):e3000. PubMed ID: 29577557
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist.
Pafili K; Trypsianis G; Papazoglou D; Maltezos E; Papanas N
Curr Vasc Pharmacol; 2020; 18(1):50-56. PubMed ID: 30156161
[TBL] [Abstract][Full Text] [Related]
15. Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus.
Chang KH; Chen CM; Lin CN; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Weng YC; Hwang JS; Kuo HC
J Peripher Nerv Syst; 2023 Dec; 28(4):651-663. PubMed ID: 37831393
[TBL] [Abstract][Full Text] [Related]
16. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus.
Pácal L; Varvařovská J; Rušavý Z; Lacigová S; Stětina R; Racek J; Pomahačová R; Tanhäuserová V; Kaňková K
Arch Physiol Biochem; 2011 Oct; 117(4):222-30. PubMed ID: 21338322
[TBL] [Abstract][Full Text] [Related]
17. The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus.
Andrade-Sierra J; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Díaz-de la Cruz EN; García-Sánchez A; Cardona-Muñoz EG; Munguía-Galaviz FJ; de Alba-Razo A; Miranda-Díaz AG
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232497
[TBL] [Abstract][Full Text] [Related]
18. Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics.
Xu J; Cai M; Wang Z; Chen Q; Han X; Tian J; Jin S; Yan Z; Li Y; Lu B; Lu H
J Endocrinol Invest; 2023 May; 46(5):869-882. PubMed ID: 36282471
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM).
Sliwinska A; Blasiak J; Kasznicki J; Drzewoski J
Chem Biol Interact; 2008 Jun; 173(3):159-65. PubMed ID: 18485337
[TBL] [Abstract][Full Text] [Related]
20. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial.
Asadi S; Gholami MS; Siassi F; Qorbani M; Khamoshian K; Sotoudeh G
Complement Ther Med; 2019 Apr; 43():253-260. PubMed ID: 30935539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
